|
Recent Newsletters
Economics & Policy: $103M to battle burnout | FDA's statin update | Heartflow to go public | Cardiologist wealth |
ARBs vs. ACE inhibitors | PCI rates down 10% | Reducing the risk of infection when CIED patients develop hematomas |
Marijuana use & stroke | Watchman FLX LAAC device safe for nonvalvular AFib | Heart health & pregnancy outcomes |
Week in Review: HeartFlow to go public | TAVR news from TVT 2021 | FDA wants to update statin warnings |
Heart disease the No. 1 killer in US | 1-year TAVR outcomes in low-risk bicuspid AS patients | AFib in young adults |
Heart Failure: Empagliflozin for HFpEF | Catheter ablation a cost-effective treatment option | HF & TEER |
IVC filter removal device earns FDA's breakthrough designation | PCI for high-risk SCAD patients | $80M in funding |